Skip to main content

Find Clinical Trials

Home
Conditions
IDH1-mutated Higher-Risk Myelodysplastic Syndromes

Clinical trial condition

IDH1-mutated Higher-Risk Myelodysplastic Syndromes

Explore clinical trials studying IDH1-mutated Higher-Risk Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

IDH1-mutated Higher-Risk Myelodysplastic Syndromes trial results

Withdrawn

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

NCT06597734

Conditions: Advanced Myeloproliferative Neoplasms, Bone Marrow Diseases, Chronic Disease, +13 more
Locations: Not specified

View Trial Details